Agios Pharmaceuticals, Inc.
AGIO
$35.00
-$2.22-5.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 42.73% | -18.68% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 42.73% | -18.68% | |||
| Cost of Revenue | 26.84% | -12.18% | |||
| Gross Profit | -24.71% | 11.23% | |||
| SG&A Expenses | 10.46% | -19.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.94% | -15.03% | |||
| Operating Income | -19.16% | 14.72% | |||
| Income Before Tax | -25.46% | 15.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -25.46% | 7.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -25.46% | 7.49% | |||
| EBIT | -19.16% | 14.72% | |||
| EBITDA | -19.41% | 14.81% | |||
| EPS Basic | -24.43% | 8.07% | |||
| Normalized Basic EPS | -24.43% | 15.81% | |||
| EPS Diluted | -24.43% | 8.07% | |||
| Normalized Diluted EPS | -24.43% | 15.81% | |||
| Average Basic Shares Outstanding | 0.82% | 0.63% | |||
| Average Diluted Shares Outstanding | 0.82% | 0.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||